摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-Methyl-4-<4-nitro-phenyl>-5-phenyl-oxazol | 92868-55-8

中文名称
——
中文别名
——
英文名称
2-Methyl-4-<4-nitro-phenyl>-5-phenyl-oxazol
英文别名
2-Methyl-5-phenyl-4-<4-nitro-phenyl>-oxazol;2-methyl-4-(4-nitro-phenyl)-5-phenyl-oxazole;2-Methyl-4-(4-nitrophenyl)-5-phenyl-1,3-oxazole
2-Methyl-4-<4-nitro-phenyl>-5-phenyl-oxazol化学式
CAS
92868-55-8
化学式
C16H12N2O3
mdl
——
分子量
280.283
InChiKey
KWYARAWBLOGQHJ-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    4.6
  • 重原子数:
    21
  • 可旋转键数:
    2
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.06
  • 拓扑面积:
    71.8
  • 氢给体数:
    0
  • 氢受体数:
    4

文献信息

  • COMBINATIONS COMPRISING AN HSP90 INHIBITOR AND A PHOPHODIESTERASE INHIBITOR FOR TREATING OR PREVENTING NEOPLASIA
    申请人:Pharmacia Corporation
    公开号:EP1682143A2
    公开(公告)日:2006-07-26
  • [EN] COMBINATIONS COMPRISING AN Hsp90 INHIBITOR AND A PHOPHODIESTERASE INHIBITOR FOR TREATING OR PREVENTING NEOPLASIA<br/>[FR] ASSOCIATION DE L'INHIBITEUR DE HSP90 ET DE L'INHIBITEUR DE LA PHOPHODIESTERASE DESTINEE A TRAITER OU PREVENIR LA NEOPLASIE
    申请人:PHARMACIA CORP
    公开号:WO2005041879A2
    公开(公告)日:2005-05-12
    A method for treating or preventing neoplasia or a neoplasia-related disorder in a subject is provided, the method comprising administering to the subject an effective amount of a combination comprising an Hsp90 inhibitor and a phosphodiesterase inhibitor, and optionally a Cox-2 inhibitor.
  • [EN] TREATMENT OR PREVENTION OF NEOPLASIA BY USE OF AN Hsp90 INHIBITOR<br/>[FR] TRAITEMENT OU PREVENTION DE LA NEOPLASIE A L'AIDE D'UN INHIBITEUR DE LA PROTEINE HSP90
    申请人:PHARMACIA CORP
    公开号:WO2005044194A2
    公开(公告)日:2005-05-19
    A method for treating or preventing neoplasia or a neoplasia-related disorder in a subject is provided, the method comprising administering to the subject an effective amount of an Hsp90 inhibitor, or of a combination comprising an Hsp90 inhibitor and a Cox-2 inhibitor.
查看更多